Statements delivered by Toshio Miyata, HGPI Executive Director about TPP’s effects on Japan’s national health insurance system at the 282nd monthly meeting of the Japan Pharma Licensing Assoc were featured in an article in Nikkan Yakugyo titled, “Miyata, HGPI Board Member Discounts Theory That TPP Threatens National Health Insurance.”